Cipla cinacalcet tablets recalled for N-nitroso cinacalcet
Cipla USA is recalling certain batches of cinacalcet 90 mg tablets because they contain higher-than-safe levels of a chemical impurity called N-Nitroso Cinacalcet. The affected bottles were distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Cipla recalls
What to do
- Check if your cinacalcet matches one of the recalled lot numbers: 4PB0224 (expires March 2026), 4PB0505, 4PB0506, 4PB0507 (expire September 2026), or 5PB0564 (expires April 2027).
- Contact your pharmacy or doctor if you have one of these lots.
- Do not stop taking your medication without talking to your doctor—they can provide a safe alternative.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
This recall covers 3 products — see all of them.
Details
- Units affected
- 63,192 bottles
- Illnesses reported
- None reported
- Manufactured in
- 10 Independence Blvd, N/A, Warren, NJ, United States
- Classification
- Class II
- Recall number
- D-0451-2026
In the FDA's words
- Description
- Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02 CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Lot, expiry: 4PB0224, exp March-2026; 4PB0505, 4PB0506, 4PB0507, exp September-2026; 5PB0564, exp April-2027 Distribution: Nationwide in the USA Affected quantity: 63,192 bottles
- Hazard
- CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
3 products in this recall
The agency lists each product separately. Check every one you might have.
- Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, I…D-0449-2026 · 113,336 bottles
- Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, I…D-0450-2026 · 96,096 bottles
- Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, I… (this page)D-0451-2026 · 63,192 bottles
More from Cipla
See all- Cipla USA fosfomycin granules recalled for failed impurity specs
ModerateFDAOct 14, 2026